Complement Factor H Variant Y402H Is a Major Risk Determinant for Geographic Atrophy and Choroidal Neovascularization in Smokers and Nonsmokers
The complement factor H (CFH) gene polymorphism Y402H (1277T-->C) has been associated with susceptibility to age-related macular degeneration (AMD). The purpose of this study was to confirm this association in a U.K. population, to determine whether the association holds for both geographic atrop...
Gespeichert in:
Veröffentlicht in: | Investigative ophthalmology & visual science 2006-02, Vol.47 (2), p.536-540 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 540 |
---|---|
container_issue | 2 |
container_start_page | 536 |
container_title | Investigative ophthalmology & visual science |
container_volume | 47 |
creator | Sepp, Tiina Khan, Jane C Thurlby, Deborah A Shahid, Humma Clayton, David G Moore, Anthony T Bird, Alan C Yates, John R. W Genetic Factors in AMD Study Group |
description | The complement factor H (CFH) gene polymorphism Y402H (1277T-->C) has been associated with susceptibility to age-related macular degeneration (AMD). The purpose of this study was to confirm this association in a U.K. population, to determine whether the association holds for both geographic atrophy (GA) and choroidal neovascularization (CNV), and to investigate interactions with smoking.
A case-control study was undertaken in 443 cases of AMD, with 262 spouses as control subjects. All subjects completed a health and lifestyle questionnaire, had an ophthalmic assessment with fundus photography, and were genotyped.
The frequencies of the C allele and CC genotype were significantly higher in cases than in controls. In comparison to the TT genotype, the odds ratios for AMD associated with the CT and CC genotypes were 3.1 (CI 2.0-4.6) and 6.3 (CI 3.8-10.4), respectively. The results were similar in subgroup analyses confined to cases with GA or CNV. The findings were also similar for subgroup analyses restricted to subjects who had never smoked, moderate smokers, or heavier smokers (>20 pack years of smoking). Heavier smokers with the CC genotype may be particularly at risk. The frequency of the CC genotype did not differ significantly between cases with and without a family history of AMD. There was no evidence that genotype had any influence on age at onset of disease.
The CFH Y402H variant is strongly associated with both GA and CNV in the U.K. population. This association is similar in smokers and nonsmokers. Heavier smokers with the CC genotype may be at particular risk. |
doi_str_mv | 10.1167/iovs.05-1143 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70693631</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70693631</sourcerecordid><originalsourceid>FETCH-LOGICAL-c349t-69515626e8d3f92c84cd0216691345bd54d151596e0a62070d92319cd7944a363</originalsourceid><addsrcrecordid>eNpF0c9PFDEUB_DGaGRFb55NL3JysL9neyQrsCSIiaCJp-bRdpjCzHRsZ9nAP8G_bNfdZE9NXz_5pu89hD5Sckypqr-G-JiPiawoFfwVmlEpWSXrOX-NZoQKVRFBxAF6l_M9IYxSRt6iA6oEp1rUM_SyiP3Y-d4PEz4DO8WEl_g3pACl8EcQtsQXGQP-Dvfl6WfID_ibn3zqw7ARTSme-3iXYGyDxSdTimP7hGFweNHGFIODDl_5-AjZrroS-wxTiAMOA77u44NP-b-9ikPeXt-jNw102X_YnYfo19npzWJZXf44v1icXFaWCz1VSksqFVN-7nijmZ0L60p3SmnKhbx1UjhahFaegGKkJk6z0rF1tRYCuOKH6GibO6b4d-XzZPqQre86GHxcZVMTpQujBX7ZQptizsk3Zkyhh_RkKDGbBZjNAgyRZrOAwj_tcle3vXd7vJt4AZ93oIwEuibBYEPeu1pIKbjeuzbcteuQvMk9dF2JpWa9XovaMCPLD_8BrLObKw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70693631</pqid></control><display><type>article</type><title>Complement Factor H Variant Y402H Is a Major Risk Determinant for Geographic Atrophy and Choroidal Neovascularization in Smokers and Nonsmokers</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Sepp, Tiina ; Khan, Jane C ; Thurlby, Deborah A ; Shahid, Humma ; Clayton, David G ; Moore, Anthony T ; Bird, Alan C ; Yates, John R. W ; Genetic Factors in AMD Study Group</creator><creatorcontrib>Sepp, Tiina ; Khan, Jane C ; Thurlby, Deborah A ; Shahid, Humma ; Clayton, David G ; Moore, Anthony T ; Bird, Alan C ; Yates, John R. W ; Genetic Factors in AMD Study Group</creatorcontrib><description>The complement factor H (CFH) gene polymorphism Y402H (1277T-->C) has been associated with susceptibility to age-related macular degeneration (AMD). The purpose of this study was to confirm this association in a U.K. population, to determine whether the association holds for both geographic atrophy (GA) and choroidal neovascularization (CNV), and to investigate interactions with smoking.
A case-control study was undertaken in 443 cases of AMD, with 262 spouses as control subjects. All subjects completed a health and lifestyle questionnaire, had an ophthalmic assessment with fundus photography, and were genotyped.
The frequencies of the C allele and CC genotype were significantly higher in cases than in controls. In comparison to the TT genotype, the odds ratios for AMD associated with the CT and CC genotypes were 3.1 (CI 2.0-4.6) and 6.3 (CI 3.8-10.4), respectively. The results were similar in subgroup analyses confined to cases with GA or CNV. The findings were also similar for subgroup analyses restricted to subjects who had never smoked, moderate smokers, or heavier smokers (>20 pack years of smoking). Heavier smokers with the CC genotype may be particularly at risk. The frequency of the CC genotype did not differ significantly between cases with and without a family history of AMD. There was no evidence that genotype had any influence on age at onset of disease.
The CFH Y402H variant is strongly associated with both GA and CNV in the U.K. population. This association is similar in smokers and nonsmokers. Heavier smokers with the CC genotype may be at particular risk.</description><identifier>ISSN: 0146-0404</identifier><identifier>ISSN: 1552-5783</identifier><identifier>EISSN: 1552-5783</identifier><identifier>DOI: 10.1167/iovs.05-1143</identifier><identifier>PMID: 16431947</identifier><identifier>CODEN: IOVSDA</identifier><language>eng</language><publisher>Rockville, MD: ARVO</publisher><subject>Aged ; Aged, 80 and over ; Alleles ; Atrophy ; Biological and medical sciences ; Case-Control Studies ; Choroidal Neovascularization - genetics ; Complement Factor H - genetics ; Eye and associated structures. Visual pathways and centers. Vision ; Female ; Fundamental and applied biological sciences. Psychology ; Gene Frequency ; Genetic Variation ; Genotype ; Humans ; Macular Degeneration - genetics ; Male ; Medical sciences ; Photoreceptor Cells, Vertebrate - pathology ; Pigment Epithelium of Eye - pathology ; Polymerase Chain Reaction ; Polymorphism, Single Nucleotide - genetics ; Risk Factors ; Smoking - genetics ; Tobacco, tobacco smoking ; Toxicology ; Vertebrates: nervous system and sense organs</subject><ispartof>Investigative ophthalmology & visual science, 2006-02, Vol.47 (2), p.536-540</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c349t-69515626e8d3f92c84cd0216691345bd54d151596e0a62070d92319cd7944a363</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17455439$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16431947$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sepp, Tiina</creatorcontrib><creatorcontrib>Khan, Jane C</creatorcontrib><creatorcontrib>Thurlby, Deborah A</creatorcontrib><creatorcontrib>Shahid, Humma</creatorcontrib><creatorcontrib>Clayton, David G</creatorcontrib><creatorcontrib>Moore, Anthony T</creatorcontrib><creatorcontrib>Bird, Alan C</creatorcontrib><creatorcontrib>Yates, John R. W</creatorcontrib><creatorcontrib>Genetic Factors in AMD Study Group</creatorcontrib><title>Complement Factor H Variant Y402H Is a Major Risk Determinant for Geographic Atrophy and Choroidal Neovascularization in Smokers and Nonsmokers</title><title>Investigative ophthalmology & visual science</title><addtitle>Invest Ophthalmol Vis Sci</addtitle><description>The complement factor H (CFH) gene polymorphism Y402H (1277T-->C) has been associated with susceptibility to age-related macular degeneration (AMD). The purpose of this study was to confirm this association in a U.K. population, to determine whether the association holds for both geographic atrophy (GA) and choroidal neovascularization (CNV), and to investigate interactions with smoking.
A case-control study was undertaken in 443 cases of AMD, with 262 spouses as control subjects. All subjects completed a health and lifestyle questionnaire, had an ophthalmic assessment with fundus photography, and were genotyped.
The frequencies of the C allele and CC genotype were significantly higher in cases than in controls. In comparison to the TT genotype, the odds ratios for AMD associated with the CT and CC genotypes were 3.1 (CI 2.0-4.6) and 6.3 (CI 3.8-10.4), respectively. The results were similar in subgroup analyses confined to cases with GA or CNV. The findings were also similar for subgroup analyses restricted to subjects who had never smoked, moderate smokers, or heavier smokers (>20 pack years of smoking). Heavier smokers with the CC genotype may be particularly at risk. The frequency of the CC genotype did not differ significantly between cases with and without a family history of AMD. There was no evidence that genotype had any influence on age at onset of disease.
The CFH Y402H variant is strongly associated with both GA and CNV in the U.K. population. This association is similar in smokers and nonsmokers. Heavier smokers with the CC genotype may be at particular risk.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Alleles</subject><subject>Atrophy</subject><subject>Biological and medical sciences</subject><subject>Case-Control Studies</subject><subject>Choroidal Neovascularization - genetics</subject><subject>Complement Factor H - genetics</subject><subject>Eye and associated structures. Visual pathways and centers. Vision</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene Frequency</subject><subject>Genetic Variation</subject><subject>Genotype</subject><subject>Humans</subject><subject>Macular Degeneration - genetics</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Photoreceptor Cells, Vertebrate - pathology</subject><subject>Pigment Epithelium of Eye - pathology</subject><subject>Polymerase Chain Reaction</subject><subject>Polymorphism, Single Nucleotide - genetics</subject><subject>Risk Factors</subject><subject>Smoking - genetics</subject><subject>Tobacco, tobacco smoking</subject><subject>Toxicology</subject><subject>Vertebrates: nervous system and sense organs</subject><issn>0146-0404</issn><issn>1552-5783</issn><issn>1552-5783</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpF0c9PFDEUB_DGaGRFb55NL3JysL9neyQrsCSIiaCJp-bRdpjCzHRsZ9nAP8G_bNfdZE9NXz_5pu89hD5Sckypqr-G-JiPiawoFfwVmlEpWSXrOX-NZoQKVRFBxAF6l_M9IYxSRt6iA6oEp1rUM_SyiP3Y-d4PEz4DO8WEl_g3pACl8EcQtsQXGQP-Dvfl6WfID_ibn3zqw7ARTSme-3iXYGyDxSdTimP7hGFweNHGFIODDl_5-AjZrroS-wxTiAMOA77u44NP-b-9ikPeXt-jNw102X_YnYfo19npzWJZXf44v1icXFaWCz1VSksqFVN-7nijmZ0L60p3SmnKhbx1UjhahFaegGKkJk6z0rF1tRYCuOKH6GibO6b4d-XzZPqQre86GHxcZVMTpQujBX7ZQptizsk3Zkyhh_RkKDGbBZjNAgyRZrOAwj_tcle3vXd7vJt4AZ93oIwEuibBYEPeu1pIKbjeuzbcteuQvMk9dF2JpWa9XovaMCPLD_8BrLObKw</recordid><startdate>20060201</startdate><enddate>20060201</enddate><creator>Sepp, Tiina</creator><creator>Khan, Jane C</creator><creator>Thurlby, Deborah A</creator><creator>Shahid, Humma</creator><creator>Clayton, David G</creator><creator>Moore, Anthony T</creator><creator>Bird, Alan C</creator><creator>Yates, John R. W</creator><creator>Genetic Factors in AMD Study Group</creator><general>ARVO</general><general>Association for Research in Vision and Ophtalmology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060201</creationdate><title>Complement Factor H Variant Y402H Is a Major Risk Determinant for Geographic Atrophy and Choroidal Neovascularization in Smokers and Nonsmokers</title><author>Sepp, Tiina ; Khan, Jane C ; Thurlby, Deborah A ; Shahid, Humma ; Clayton, David G ; Moore, Anthony T ; Bird, Alan C ; Yates, John R. W ; Genetic Factors in AMD Study Group</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c349t-69515626e8d3f92c84cd0216691345bd54d151596e0a62070d92319cd7944a363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Alleles</topic><topic>Atrophy</topic><topic>Biological and medical sciences</topic><topic>Case-Control Studies</topic><topic>Choroidal Neovascularization - genetics</topic><topic>Complement Factor H - genetics</topic><topic>Eye and associated structures. Visual pathways and centers. Vision</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene Frequency</topic><topic>Genetic Variation</topic><topic>Genotype</topic><topic>Humans</topic><topic>Macular Degeneration - genetics</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Photoreceptor Cells, Vertebrate - pathology</topic><topic>Pigment Epithelium of Eye - pathology</topic><topic>Polymerase Chain Reaction</topic><topic>Polymorphism, Single Nucleotide - genetics</topic><topic>Risk Factors</topic><topic>Smoking - genetics</topic><topic>Tobacco, tobacco smoking</topic><topic>Toxicology</topic><topic>Vertebrates: nervous system and sense organs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sepp, Tiina</creatorcontrib><creatorcontrib>Khan, Jane C</creatorcontrib><creatorcontrib>Thurlby, Deborah A</creatorcontrib><creatorcontrib>Shahid, Humma</creatorcontrib><creatorcontrib>Clayton, David G</creatorcontrib><creatorcontrib>Moore, Anthony T</creatorcontrib><creatorcontrib>Bird, Alan C</creatorcontrib><creatorcontrib>Yates, John R. W</creatorcontrib><creatorcontrib>Genetic Factors in AMD Study Group</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Investigative ophthalmology & visual science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sepp, Tiina</au><au>Khan, Jane C</au><au>Thurlby, Deborah A</au><au>Shahid, Humma</au><au>Clayton, David G</au><au>Moore, Anthony T</au><au>Bird, Alan C</au><au>Yates, John R. W</au><au>Genetic Factors in AMD Study Group</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Complement Factor H Variant Y402H Is a Major Risk Determinant for Geographic Atrophy and Choroidal Neovascularization in Smokers and Nonsmokers</atitle><jtitle>Investigative ophthalmology & visual science</jtitle><addtitle>Invest Ophthalmol Vis Sci</addtitle><date>2006-02-01</date><risdate>2006</risdate><volume>47</volume><issue>2</issue><spage>536</spage><epage>540</epage><pages>536-540</pages><issn>0146-0404</issn><issn>1552-5783</issn><eissn>1552-5783</eissn><coden>IOVSDA</coden><abstract>The complement factor H (CFH) gene polymorphism Y402H (1277T-->C) has been associated with susceptibility to age-related macular degeneration (AMD). The purpose of this study was to confirm this association in a U.K. population, to determine whether the association holds for both geographic atrophy (GA) and choroidal neovascularization (CNV), and to investigate interactions with smoking.
A case-control study was undertaken in 443 cases of AMD, with 262 spouses as control subjects. All subjects completed a health and lifestyle questionnaire, had an ophthalmic assessment with fundus photography, and were genotyped.
The frequencies of the C allele and CC genotype were significantly higher in cases than in controls. In comparison to the TT genotype, the odds ratios for AMD associated with the CT and CC genotypes were 3.1 (CI 2.0-4.6) and 6.3 (CI 3.8-10.4), respectively. The results were similar in subgroup analyses confined to cases with GA or CNV. The findings were also similar for subgroup analyses restricted to subjects who had never smoked, moderate smokers, or heavier smokers (>20 pack years of smoking). Heavier smokers with the CC genotype may be particularly at risk. The frequency of the CC genotype did not differ significantly between cases with and without a family history of AMD. There was no evidence that genotype had any influence on age at onset of disease.
The CFH Y402H variant is strongly associated with both GA and CNV in the U.K. population. This association is similar in smokers and nonsmokers. Heavier smokers with the CC genotype may be at particular risk.</abstract><cop>Rockville, MD</cop><pub>ARVO</pub><pmid>16431947</pmid><doi>10.1167/iovs.05-1143</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0146-0404 |
ispartof | Investigative ophthalmology & visual science, 2006-02, Vol.47 (2), p.536-540 |
issn | 0146-0404 1552-5783 1552-5783 |
language | eng |
recordid | cdi_proquest_miscellaneous_70693631 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Aged Aged, 80 and over Alleles Atrophy Biological and medical sciences Case-Control Studies Choroidal Neovascularization - genetics Complement Factor H - genetics Eye and associated structures. Visual pathways and centers. Vision Female Fundamental and applied biological sciences. Psychology Gene Frequency Genetic Variation Genotype Humans Macular Degeneration - genetics Male Medical sciences Photoreceptor Cells, Vertebrate - pathology Pigment Epithelium of Eye - pathology Polymerase Chain Reaction Polymorphism, Single Nucleotide - genetics Risk Factors Smoking - genetics Tobacco, tobacco smoking Toxicology Vertebrates: nervous system and sense organs |
title | Complement Factor H Variant Y402H Is a Major Risk Determinant for Geographic Atrophy and Choroidal Neovascularization in Smokers and Nonsmokers |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T10%3A13%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Complement%20Factor%20H%20Variant%20Y402H%20Is%20a%20Major%20Risk%20Determinant%20for%20Geographic%20Atrophy%20and%20Choroidal%20Neovascularization%20in%20Smokers%20and%20Nonsmokers&rft.jtitle=Investigative%20ophthalmology%20&%20visual%20science&rft.au=Sepp,%20Tiina&rft.date=2006-02-01&rft.volume=47&rft.issue=2&rft.spage=536&rft.epage=540&rft.pages=536-540&rft.issn=0146-0404&rft.eissn=1552-5783&rft.coden=IOVSDA&rft_id=info:doi/10.1167/iovs.05-1143&rft_dat=%3Cproquest_cross%3E70693631%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70693631&rft_id=info:pmid/16431947&rfr_iscdi=true |